Technology
The FTC has initiated a lawsuit against Hims & Hers, accusing the telehealth firm of deceptive practices in consumer health data handling.
Finance
The end of Medicare drug subsidies is set to elevate out-of-pocket costs for older adults, providing Democrats with a potent campaign issue for the midterms.
Technology
A fugitive assumed a new life in biotech, while a New Hampshire hospital challenges Eli Lilly's controversial pricing policies under the 340B program.
Technology
The debate over benchmarking clinical AI systems highlights the challenges of interpreting results beyond headlines.
Technology
The FDA's expert committee reviews Capricor's deramiocel, a potential Duchenne treatment, raising questions about its efficacy and trial integrity.
Technology
A recent study reveals clinical AI models underperform compared to generalist models, sparking debate in the health AI community.
Technology
The revelation of a fugitive's secret biotech career sparks scrutiny over hiring practices and vetting processes in the industry.
Sports
Prolonged hospitalizations can lead to serious emotional and developmental issues in children due to isolation, highlighting the need for structured support.
Finance
Despite a horror renaissance, space horror films have faded from Hollywood. Explore why the genre isn't taking off again on the cinematic stage.
Finance
In an exclusive interview, astronaut Michael Foale shares his experiences during the 1997 Mir space station collision and the challenges that followed.
Technology
Explore the legacy of Viking 1's Mars landing as experts discuss its findings and the latest developments in space exploration.
Finance
The recent Cyclospora outbreak highlights the urgent need for improved food safety measures to protect public health while promoting nutritious diets.
Sports
The U.S. has surpassed its 2025 measles case count, signifying a public health crisis driven by falling vaccination rates and significant outbreaks across several states.
Technology
A tragic incident involving a six-year-old girl’s death from experimental CRISPR therapy in China has sparked urgent ethical discussions in biotech.
Technology
An FDA advisory panel endorses peptide accessibility, while Sanofi's insulin pen faces supply shortages, impacting diabetes patients nationwide.